[{"NetIncomeLoss_1_Q1_USD":41524000.0,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":4863000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":548000.0,"ProceedsFromDivestitureOfBusinesses_1_Q1_USD":818000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-17048000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":36100000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-216061000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":1692000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":156047000.0,"LongTermDebtFairValue_0_Q1_USD":8400000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":315448000.0,"DepreciationAndAmortization_1_Q1_USD":118485000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":3000000.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_1_Q1_USD":54924000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q1_USD":41578000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":3000000.0,"OperatingLeaseLiability_0_Q1_USD":47551000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":855405000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":8120000.0,"ShareBasedCompensation_1_Q1_USD":9993000.0,"StockholdersEquityOther_1_Q1_USD":2000.0,"RestructuringReserveAcceleratedDepreciation_1_Q1_USD":6900000.0,"Assets_0_Q1_USD":9234171000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":104511000.0,"CommonStockSharesIssued_0_Q1_shares":231459092.0,"GainLossRelatedToLitigationSettlement_1_Q1_USD":-637000.0,"AssetsCurrent_0_Q1_USD":2495231000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q1_USD":4552231000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":622000.0,"LossContingencyAccrualAtCarryingValue_0_Q1_USD":327900000.0,"ContractWithCustomerLiability_0_Q1_USD":5887000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":23355000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":187174000.0,"LongTermDebtCurrent_0_Q1_USD":200342000.0,"LongTermDebt_0_Q1_USD":8277964000.0,"FinanceLeaseInterestExpense_1_Q1_USD":367000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":34389000.0,"FinanceLeaseLiability_0_Q1_USD":29731000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1427775000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-44868000.0,"CommonStockValue_0_Q1_USD":23000.0,"NumberOfReportableSegments_1_Q1_segment":4.0,"IncomeTaxExpenseBenefit_1_Q1_USD":724000.0,"AccountsReceivableNetCurrent_0_Q1_USD":473152000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":979000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":-13753000.0,"InterestPayableCurrent_0_Q1_USD":125074000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":238671000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":399000.0,"DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_1_Q1_USD":-0.02,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":358856000.0,"EarningsPerShareBasic_1_Q1_USD":0.18,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":4248085000.0,"DeferredFinanceCostsGross_0_Q1_USD":56700000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":29739000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":1321000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":35738000.0,"ContractWithCustomerAssetNet_0_Q1_USD":13025000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":6892074000.0,"OtherAssetsNoncurrent_0_Q1_USD":46551000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":95130000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":101658000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":43216000.0,"IncreaseDecreaseInInventories_1_Q1_USD":3802000.0,"GainLossOnSaleOfBusiness_1_Q1_USD":-355000.0,"IndefinitelivedIntangibleAssetsAcquired_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_1_Q1_USD":0.0,"IncomeLossFromContinuingOperations_1_Q1_USD":47059000.0,"InterestPaidCapitalized_1_Q1_USD":1133000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-5453000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":387000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1_Q1_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-47350000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.015,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-1385000.0,"ProceedsFromNotesPayable_1_Q1_USD":1279978000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q1_USD":223142000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":1828000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"InterestExpense_1_Q1_USD":134341000.0,"NonoperatingIncomeExpense_1_Q1_USD":-912000.0,"LiabilitiesCurrent_0_Q1_USD":1395492000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q1_USD":2882000.0,"CostOfRevenue_1_Q1_USD":305293000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":6861000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":230551000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1564841000.0,"RepaymentsOfDebt_1_Q1_USD":1321000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":243840000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9993000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":4863000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":47783000.0,"Goodwill_0_Q1_USD":3560011000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q1_USD":15000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":1692000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":101622000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":280394000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":-500000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":622000.0,"InventoryNoncurrent_0_Q1_USD":7400000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":24352000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":82563000.0,"OperatingLeasePayments_1_Q1_USD":2883000.0,"AdditionalPaidInCapital_0_Q1_USD":8943764000.0,"ProceedsFromIssuanceOfOtherLongTermDebt_1_Q1_USD":1980000000.0,"RepaymentsOfOtherLongTermDebt_1_Q1_USD":3295475000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":86056000.0,"SubleaseIncome_1_Q1_USD":933000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q1_USD":0.2,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2643989000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":36000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":121737000.0,"LongTermDebtNoncurrent_0_Q1_USD":8077622000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":-1719000.0,"IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_1_Q1_USD":0.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":2311000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-151000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":13600000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":258643000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":45238000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q1_USD":394600000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":9234171000.0,"OperatingLeaseCost_1_Q1_USD":3736000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":6889074000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1400000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q1_USD":2882000.0,"IncomeTaxesReceivable_0_Q1_USD":9002000.0,"AccountsPayableTradeCurrent_0_Q1_USD":104524000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":717919000.0,"CommonStockSharesAuthorized_0_Q1_shares":1000000000.0,"DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_1_Q1_USD":-0.03,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-16606000.0,"DebtInstrumentFaceAmount_0_Q1_USD":8375968000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q1_USD":452172000.0,"InventoryNet_0_Q1_USD":362180000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":11813000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q1_USD":-5535000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":373653000.0,"EarningsPerShareDiluted_1_Q1_USD":0.17,"CommonStockSharesOutstanding_0_Q1_shares":230315768.0,"AssetImpairmentCharges_1_Q1_USD":3309000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-37182000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":179841000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-9326746000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q1_USD":0.2,"VariableLeaseCost_1_Q1_USD":3022000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":3551000.0,"LossContingencyAccrualCarryingValueCurrent_0_Q1_USD":327896000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":16733000.0,"StockholdersEquity_0_Q1_USD":-598973000.0,"FinitelivedIntangibleAssetsAcquired1_1_Q1_USD":0.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":6376000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":299940000.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_1_Q1_USD":3583000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":137066000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q1_USD":-5022000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-141000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]